JANSSEN BIOTECH
Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative "firsts," Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, They dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.
JANSSEN BIOTECH
Industry:
Biotechnology Health Care
Founded:
1979-01-01
Address:
Horsham, Pennsylvania, United States
Country:
United States
Website Url:
http://www.janssenbiotech.com
Total Employee:
10001+
Status:
Active
Contact:
2153254232
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Mobile Non Scaleable Content Euro
Similar Organizations
Geneius
Geneius is a Biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-05-02 | BeneVir Biopharm | BeneVir Biopharm acquired by Janssen Biotech | N/A |
| 2008-01-01 | Centocor Ortho Biotech | Centocor Ortho Biotech acquired by Janssen Biotech | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-14 | Halozyme Therapeutics | Janssen Biotech investment in Post-IPO Equity - Halozyme Therapeutics | 15 M USD |
| 2013-07-15 | Amphivena Therapeutics | Janssen Biotech investment in Series A - Amphivena Therapeutics | 14 M USD |
Official Site Inspections
http://www.janssenbiotech.com Semrush global rank: 5.39 M Semrush visits lastest month: 1.56 K
- Host name: aa089eb6179d1ae2b.awsglobalaccelerator.com
- IP address: 76.223.34.124
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Janssen Biotech"
Company | Janssen
6 days ago Get to know our leaders. Read their unique perspectives on how they are working to change the trajectory of health. See More >See details»
Janssen Biotech - Crunchbase Company Profile & Funding
Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative "firsts," …See details»
About Janssen Global - Janssen United States
May 5, 2015 At Janssen, the Pharmaceutical Companies of Johnson & Johnson, working on incremental improvements to healthcare is not enough. We leverage our scientific expertise …See details»
Janssen Pharmaceuticals - Wikipedia
The early roots of what would become Janssen Pharmaceuticals date back to 1933. In 1933, Constant Janssen, the father of Paul Janssen, acquired the right to distribute the pharmaceutical products of Richter, a Hungarian pharmaceutical company, for Belgium, the Netherlands and Belgian Congo. On 23 October 1934, he founded the N.V. Produkten Richter in Turnhout. In 1937, Constant J…See details»
Canada | Janssen
3 days ago Get to know our leaders. Read their unique perspectives on how they are working to change the trajectory of health. See More >See details»
JANSSEN BIOTECH, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for JANSSEN BIOTECH, INC. of Malvern, PA. Get the latest business insights from Dun & Bradstreet.See details»
We are here to transform the future of health - Janssen …
Sep 26, 2024 We at Johnson & Johnson are entrusted with one of the most important jobs in the world. We aspire to transform lives by bringing life-saving and life-changing solutions to people who need them.See details»
The Janssen Pharmaceutical Companies of Johnson & Johnson
The Janssen Pharmaceutical Companies of Johnson & Johnson Pharmaceutical Manufacturing Raritan, New Jersey 1,041,102 followersSee details»
Our heritage - innovativemedicine.jnj.com
In 2010, the pharmaceutical companies of Johnson & Johnson adopted a common identity—the Janssen Pharmaceutical Companies of Johnson & Johnson. Coming together as “One Team” …See details»
About Janssen Biotech, Inc. - STELARA® (ustekinumab)
Janssen Biotech, Inc., redefines the standard of care in immunology, nephrology, and oncology. Built upon a pioneering history, Janssen Biotech harnesses innovations in large-molecule and …See details»
Janssen Biotech - Overview, News & Similar companies - ZoomInfo
Janssen Biotech Inc is a company that operates in the Biotechnology industry. It employs 21-50 people and has $1M-$5M of revenue. The company is he adquartered in Horsham, …See details»
Janssen Company Profile | Management and Employees List
SQL International Organization for Standardization . Enterprise Resource Planning (11 Technologies) SAP SAP . SAP Financial Supply Chain Management SAP . SAP S/4HANA …See details»
Janssen’s Legacy of Advancement, Beerse, Belgium - Johnson
In 1961, Johnson & Johnson acquired Janssen Pharmaceutica, the innovative drug company and research lab focused on public health. The company was founded in 1953 by Belgian-born Dr. …See details»
About us - Janssen
Inspired by patients, and the legacy of industry pioneer Dr. Paul Janssen, we continue with the vision of developing science-based innovations to change and save lives.See details»
Janssen Vaccines - Wikipedia
Janssen Vaccines in Leiden developed the COVID-19 vaccines for Johnson & Johnson. Initial production of the vaccine is happening at Janssen Biotech in Leiden, Netherlands. The …See details»
Janssen Enters Worldwide Collaboration and License Agreement …
HORSHAM, Pa., May 2, 2023 – Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into a worldwide …See details»
The world is our lab | Janssen Belgium
Our goal is to identify the best ideas inside and outside our organization to tackle the biggest unmet medical needs of our time. We also want to challenge attitudes towards diseases and …See details»
Johnson & Johnson submits application to the European …
Dec 18, 2024 Ibrutinib is a once-daily oral medication that is jointly developed and commercialised by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie company. 4 …See details»
Meet our leadership team - Janssen
Sep 26, 2024 Federico Feldstein is the Vice President and Chief Quality Officer of Innovative Medicine at Johnson & Johnson. In his current role, Federico leads the Innovative Medicine …See details»
NORTH AMERICA - Janssen
6 days ago We’re committed to showing the heart of the caregiver’s experience and providing the kind of support and information that will make a difference.See details»